Iridex Stock Market Value
| IRIX Stock | USD 1.46 0.03 2.10% |
| Symbol | IRIDEX |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRIDEX. Market participants price IRIDEX higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive IRIDEX assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.32) | Revenue Per Share | Quarterly Revenue Growth 0.078 | Return On Assets | Return On Equity |
IRIDEX's market price often diverges from its book value, the accounting figure shown on IRIDEX's balance sheet. Smart investors calculate IRIDEX's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since IRIDEX's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IRIDEX's value and its price as these two are different measures arrived at by different means. Investors typically determine if IRIDEX is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRIDEX's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IRIDEX 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IRIDEX's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IRIDEX.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in IRIDEX on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding IRIDEX or generate 0.0% return on investment in IRIDEX over 90 days. IRIDEX is related to or competes with Adagio Medical, Envoy Medical, Pulmatrix, Vivos Therapeutics, Aspire BioPharma, Allurion Technologies, and Palisade Bio. IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices... More
IRIDEX Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IRIDEX's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess IRIDEX upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.19 | |||
| Information Ratio | 0.0949 | |||
| Maximum Drawdown | 35.45 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 7.89 |
IRIDEX Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IRIDEX's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IRIDEX's standard deviation. In reality, there are many statistical measures that can use IRIDEX historical prices to predict the future IRIDEX's volatility.| Risk Adjusted Performance | 0.0979 | |||
| Jensen Alpha | 0.5152 | |||
| Total Risk Alpha | 0.0573 | |||
| Sortino Ratio | 0.1024 | |||
| Treynor Ratio | 0.505 |
IRIDEX February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0979 | |||
| Market Risk Adjusted Performance | 0.515 | |||
| Mean Deviation | 3.47 | |||
| Semi Deviation | 4.61 | |||
| Downside Deviation | 5.19 | |||
| Coefficient Of Variation | 901.96 | |||
| Standard Deviation | 5.61 | |||
| Variance | 31.45 | |||
| Information Ratio | 0.0949 | |||
| Jensen Alpha | 0.5152 | |||
| Total Risk Alpha | 0.0573 | |||
| Sortino Ratio | 0.1024 | |||
| Treynor Ratio | 0.505 | |||
| Maximum Drawdown | 35.45 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 7.89 | |||
| Downside Variance | 26.98 | |||
| Semi Variance | 21.28 | |||
| Expected Short fall | (4.09) | |||
| Skewness | 1.24 | |||
| Kurtosis | 11.18 |
IRIDEX Backtested Returns
IRIDEX appears to be dangerous, given 3 months investment horizon. IRIDEX holds Efficiency (Sharpe) Ratio of 0.0852, which attests that the entity had a 0.0852 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for IRIDEX, which you can use to evaluate the volatility of the firm. Please utilize IRIDEX's Semi Deviation of 4.61, risk adjusted performance of 0.0979, and Market Risk Adjusted Performance of 0.515 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, IRIDEX holds a performance score of 6. The company retains a Market Volatility (i.e., Beta) of 1.21, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, IRIDEX will likely underperform. Please check IRIDEX's treynor ratio, as well as the relationship between the expected short fall and day median price , to make a quick decision on whether IRIDEX's current trending patterns will revert.
Auto-correlation | 0.07 |
Virtually no predictability
IRIDEX has virtually no predictability. Overlapping area represents the amount of predictability between IRIDEX time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of IRIDEX price movement. The serial correlation of 0.07 indicates that barely 7.0% of current IRIDEX price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.07 | |
| Spearman Rank Test | 0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for IRIDEX Stock Analysis
When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.